Skip to search formSkip to main contentSkip to account menu

olaparib 50 MG Oral Capsule

Known as: OLAPARIB 50MG CAP,ORAL, OLAPARIB 50MG CAP,ORAL [VA Product], OLAPARIB 50MG ORAL CAP 
National Institutes of Health

Related topics

Related topics

5 relations

Broader (1)

Antimetabolites, Antineoplastic
Oral CapsulePoly(ADP-Ribose) Polymerase Inhibitors [MoA]olaparib

Narrower (1)

olaparib 50 MG Oral Capsule [Lynparza]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2020
Review
2020
Abstract OT2-03-01: A phase one trial of olaparib with radiation therapy in patients with triple negative breast cancer: RADIOPARP
Background Preclinical studies have shown that breast cancer (BC) cell lines with a triple-negative phenotype are more sensitive… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)